FACTX
Price
$52.79
Change
-$0.02 (-0.04%)
Updated
Oct 6 closing price
Net Assets
3.28B
JNGLX
Price
$73.94
Change
-$0.13 (-0.18%)
Updated
Oct 6 closing price
Net Assets
4.49B
Interact to see
Advertisement

FACTX vs JNGLX

Header iconFACTX vs JNGLX Comparison
Open Charts FACTX vs JNGLXBanner chart's image
Fidelity Advisor Health Care M
Price$52.79
Change-$0.02 (-0.04%)
VolumeN/A
Net Assets3.28B
Janus Henderson Global Life Sciences D
Price$73.94
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets4.49B
FACTX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
FACTX vs. JNGLX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACTX is a Buy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.49B vs. FACTX (3.28B). JNGLX pays higher dividends than FACTX: JNGLX (0.33) vs FACTX (0.00). FACTX was incepted earlier than JNGLX: FACTX (29 years) vs JNGLX (27 years). FACTX (1.18) is less costly to investors than JNGLX (0.80). FACTX is a more actively managed with annual turnover of: 37.00 vs. JNGLX (35.00). FACTX has a lower initial minimum investment than JNGLX: FACTX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -6.32 vs. FACTX (-13.55). JNGLX return over 5 years is better than : 9.99 vs. FACTX (-11.23).
FACTXJNGLXFACTX / JNGLX
Total Expense Ratio1.180.80147%
Annual Report Gross Expense Ratio1.180.80147%
Fund Existence29 years27 years-
Gain YTD5.5369.10361%
Front Load4%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.28B4.49B73%
Annual Yield % from dividends0.000.33-
Returns for 1 year-13.55-6.32214%
Returns for 3 years4.6624.1619%
Returns for 5 years-11.239.99-112%
Returns for 10 years55.6640.22138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AOFAX20.65N/A
N/A
Alger Small Cap Focus A
CCCRX40.10N/A
N/A
Columbia Contrarian Core R
MVGJX18.64N/A
N/A
MFS Low Volatility Global Equity R1
TIOVX17.75N/A
N/A
Nuveen International Opps W
GRETX11.49N/A
N/A
Goldman Sachs Real Estate Securities Inv